Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Assessing newborn scalp hair can reveal important health information.

Phosphatidic acid may help hair grow by affecting cell growth pathways.

Melatonin improved mental health and metabolism in women with PCOS.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Certain DNA variants can predict straight hair in Europeans but are not highly specific.

Minoxidil effectively treats female pattern hair loss.

High doses of finasteride cause cell growth and tumors in mice.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.